The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota
Open accessAbstract
UNLABELLED: Cervicovaginal mucus (CVM) can provide a barrier that precludes HIV and other sexually transmitted virions from reaching target cells in the vaginal epithelium, thereby preventing or reducing infections. However, the barrier properties of CVM differ from woman to woman, and the causes of these variations are not yet well understood. Using high-resolution particle tracking of fluorescent HIV-1 pseudoviruses, we found that neither pH nor Nugent scores nor total lactic acid levels correlated significantly with virus trapping in unmodified CVM from diverse donors. Surprisingly, HIV-1 was generally trapped in CVM with relatively high concentrations of d-lactic acid and a Lactobacillus crispatus-dominant microbiota. In contrast, a substantial fraction of HIV-1 virions diffused rapidly through CVM with low concentrations of d-lactic acid that had a Lactobacillus iners-dominant microbiota or significant amounts of Gardnerella vaginalis, a bacterium associated with bacterial vaginosis. Our results demonstrate that the vaginal microbiota, including specific species of Lactobacillus, can alter the diffusional barrier properties of CVM against HIV and likely other sexually transmitted viruses and that these microbiota-associated changes may account in part for the elevated risks of HIV acquisition linked to bacterial vaginosis or intermediate vaginal microbiota. IMPORTANCE: Variations in the vaginal microbiota, especially shifts away from Lactobacillus-dominant microbiota, are associated with differential risks of acquiring HIV or other sexually transmitted infections. However, emerging evidence suggests that Lactobacillus iners frequently colonizes women with recurring bacterial vaginosis, raising the possibility that L. iners may not be as protective as other Lactobacillus species. Our study was designed to improve understanding of how the cervicovaginal mucus barrier against HIV may vary between women along with the vaginal microbiota and led to the finding that the vaginal microbiota, including specific species of Lactobacillus, can directly alter the diffusional barrier properties of cervicovaginal mucus. This work advances our understanding of the complex barrier properties of mucus and highlights the differential protective ability of different species of Lactobacillus, with Lactobacillus crispatus and possibly other species playing a key role in protection against HIV and other sexually transmitted infections. These findings could lead to the development of novel strategies to protect women against HIV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A Lactobacillus crispatus-dominant microbiota has been shown to impede the diffusion of HIV-1 virions, in contrast to the rapid diffusion observed with a Lactobacillus iners-dominant microbiota, or when Gardnerella vaginalis is present in significant amounts (Nunn et al., 2015).”
From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Nunn et al., 2015
In the citing paper
“A L. crispatus-dominated vaginal microbiota produces high concentrations of D-lactate which has been recently shown to increase cervicovaginal mucus viscosity and enhance its viral particle trapping potential (Nunn et al., 2015), and tends to have the least likelihood of viral infections of all CSTs (Borgdorff et al., 2014).”
From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Nunn et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaginal microbiome of reproductive-age women
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002611107 · Cited by 4,254
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Masters, W. H., & Johnson, V. E. (1966) · Medical Entomology and Zoology · Cited by 3,080
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
Self-citationTemporal Dynamics of the Human Vaginal Microbiota
Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J. M., Schütte, U. M. E., Zhong, X., Koenig, S. S. K., Fu, L., Ma, Z. S., Zhou, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003605 · Cited by 1,583
Micro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,268
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
Sewankambo, N. K., Gray, R. H., Wawer, M. J., Paxton, L. A., McNairn, D., Wabwire‐Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01063-5 · Cited by 657
Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
O’Hanlon, D. E., Moench, T. R., & Cone, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080074 · Cited by 548
Cited by
Sorted by citations
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696
The role of lactic acid production by probiotic Lactobacillus species in vaginal health
Tachedjian, G., Aldunate, M., Bradshaw, C. S., & Cone, R. A. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.04.001 · Cited by 557
Mitra, A., MacIntyre, D. A., Marchesi, J. R., Lee, Y. S., Bennett, P. R., & Kyrgiou, M. (2016) · Microbiome · doi:10.1186/s40168-016-0203-0 · Cited by 484
The vaginal microbiota, host defence and reproductive physiology
Smith, S. B., & Ravel, J. (2016) · The Journal of Physiology · doi:10.1113/jp271694 · Cited by 449
Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?
Miller, E. A., Beasley, D. E., Dunn, R. R., & Archie, E. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01936 · Cited by 411
Norenhag, J., Du, J., Olovsson, M., Verstraelen, H., Engstrand, L. G., & Brusselaers, N. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15854 · Cited by 405
Kindinger, L. M., Bennett, P. R., Lee, Y. S., Marchesi, J. R., Smith, A., Cacciatore, S., Holmes, E., Nicholson, J. K., Teoh, T. G., & MacIntyre, D. A. (2017) · Microbiome · doi:10.1186/s40168-016-0223-9 · Cited by 372
Ecology, evolution and spillover of coronaviruses from bats
Ruiz‐Aravena, M., McKee, C., Gamble, A., Lunn, T. J., Morris, A. L., Snedden, C. E., Yinda, C. K., Port, J. R., Buchholz, D. W., Yeo, Y. Y., et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00652-2 · Cited by 303
Kalia, N., Singh, J., & Kaur, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-0347-4 · Cited by 308
Lewis, F. M. T., Bernstein, K. T., & Aral, S. O. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001932 · Cited by 248
Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections
Torcia, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020266 · Cited by 203
Newby, J., Schaefer, A., Lee, P. T., Forest, M. G., & Lai, S. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804420115 · Cited by 197
Barrientos‐Durán, A., Fuentes, A. P., de Salazar, A., Plaza‐Díaz, J., & García, F. (2020) · Nutrients · doi:10.3390/nu12020419 · Cited by 188
Viral Infections, the Microbiome, and Probiotics
Harper, A., Vijayakumar, V., Ouwehand, A. C., ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., & Day, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.596166 · Cited by 177
Lennard, K. S., Dabee, S., Barnabas, S. L., Havyarimana, E., Blakney, A. K., Jaumdally, S. Z., Botha, G., Mkhize, N. N., Bekker, L., Lewis, D. A., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00410-17 · Cited by 173
The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection
Edwards, V. L., Smith, S. B., McComb, E. J., Tamarelle, J., Ma, B., Humphrys, M. S., Gajer, P., Gwilliam, K., Schaefer, A., Lai, S. K., et al. (2019) · mBio · doi:10.1128/mbio.01548-19 · Cited by 170
A slippery slope: On the origin, role and physiology of mucus
Taherali, F., Varum, F., & Basit, A. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.014 · Cited by 177
Pathogens, microbiome and the host: emergence of the ecological Koch's postulates
Vonaesch, P., Anderson, M. C., & Sansonetti, P. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy003 · Cited by 177
Selective permeability of mucus barriers
Witten, J. J., Samad, T. S., & Ribbeck, K. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.010 · Cited by 176
Graspeuntner, S., Loeper, N., Künzel, S., Baines, J. F., & Rupp, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27757-8 · Cited by 168
The Cervicovaginal Mucus Barrier
Lacroix, G., Gouyer, V., Gottrand, F., & Desseyn, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218266 · Cited by 148
Crosstalk between Vaginal Microbiome and Female Health: A review
Gupta, S., Kakkar, V., & Bhushan, I. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103696 · Cited by 151
Lactobacillus iners, the unusual suspect
Vaneechoutte, M. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.09.003 · Cited by 134
Brooks, J. P., Edwards, D., Blithe, D., Fettweis, J. M., Serrano, M. G., Sheth, N. U., Strauss, J. F., Buck, G. A., & Jefferson, K. K. (2016) · Contraception · doi:10.1016/j.contraception.2016.11.006 · Cited by 128
Mauro, V. P. (2018) · BioDrugs · doi:10.1007/s40259-018-0261-x · Cited by 129
Tachedjian, G., O’Hanlon, D. E., & Ravel, J. (2018) · Microbiome · doi:10.1186/s40168-018-0418-3 · Cited by 125
Vaginal microbiota and susceptibility to HIV
Eastment, M. C., & McClelland, R. S. (2018) · AIDS · doi:10.1097/qad.0000000000001768 · Cited by 114
Delgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01337-5 · Cited by 126
The gut microbiome in human immunodeficiency virus infection
Zilberman-Schapira, G., Zmora, N., Itav, S., Bashiardes, S., Elinav, H., & Elinav, E. (2016) · BMC Medicine · doi:10.1186/s12916-016-0625-3 · Cited by 117
Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid
Tyssen, D. P., Wang, Y., Hayward, J. A., Agius, P. A., DeLong, K., Aldunate, M., Ravel, J., Moench, T. R., Cone, R. A., & Tachedjian, G. (2018) · mSphere · doi:10.1128/msphere.00055-18 · Cited by 117
Watchorn, J., Clasky, A. J., Prakash, G., Johnston, I. A. E., Chen, P., & Gu, F. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00047 · Cited by 119
Volz, E., & Didelot, X. (2018) · Systematic Biology · doi:10.1093/sysbio/syy007 · Cited by 102
France, M., Fu, L., Rutt, L., Yang, H., Humphrys, M. S., Narina, S., Gajer, P., Ma, B., Forney, L. J., & Ravel, J. (2022) · Genome biology · doi:10.1186/s13059-022-02635-9 · Cited by 106
Interactions between microbiota and cervical epithelial, immune, and mucus barrier
Dong, M., Dong, Y., Bai, J., Li, H., Ma, X., Li, B., Wang, C., Li, H., Qi, W., Wang, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1124591 · Cited by 113
Wessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102
Reimers, L., Mehta, S. D., Massad, L. S., Burk, R. D., Xie, X., Ravel, J., Cohen, M. H., Palefsky, J. M., Weber, K. M., Xue, X., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw374 · Cited by 99
Associations between the vaginal microbiome and Candida colonization in women of reproductive age
Tortelli, B. A., Lewis, W. G., Allsworth, J. E., Member-Meneh, N., Foster, L. R., Reno, H., Peipert, J. F., Fay, J. C., & Lewis, A. L. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.10.008 · Cited by 96
Interactions between reproductive biology and microbiomes in wild animal species
Comizzoli, P., Power, M. L., Bornbusch, S. L., & Muletz‐Wolz, C. R. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00156-7 · Cited by 96
Foschi, C., Salvo, M., Cevenini, R., Parolin, C., Vitali, B., & Marangoni, A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00502 · Cited by 86
Joag, V., Obila, O., Gajer, P., Scott, M. C., Dizzell, S., Humphrys, M., Shahabi, K., Huibner, S., Shannon, B., Tharao, W., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy762 · Cited by 84
Commensal inter-bacterial interactions shaping the microbiota
Kern, L., Abdeen, S. K., Kolodziejczyk, A. A., & Elinav, E. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.07.011 · Cited by 82
Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo
Palomino, R. A. Ñ., Zicari, S., Vanpouille, C., Vitali, B., & Margolis, L. B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00906 · Cited by 78
The Complex Link between the Female Genital Microbiota, Genital Infections, and Inflammation
Dabee, S., Passmore, J.-A. S., Heffron, R., & Jaspan, H. B. (2021) · Infection and Immunity · doi:10.1128/iai.00487-20 · Cited by 89
Holm, J. B., France, M., Gajer, P., Ma, B., Brotman, R. M., Shardell, M. D., Forney, L. J., & Ravel, J. (2023) · Microbiome · doi:10.1186/s40168-023-01692-x · Cited by 76
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
Hoang, T., Toler, E., DeLong, K., Mafunda, N. A., Bloom, S. M., Zierden, H. C., Moench, T. R., Coleman, J. S., Hanes, J. S., Kwon, D. S., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008236 · Cited by 78
The interplay between human papillomavirus and vaginal microbiota in cervical cancer development
Sharifian, K., Shoja, Z., & Jalilvand, S. (2023) · Virology Journal · doi:10.1186/s12985-023-02037-8 · Cited by 81
das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 74
Microbiota metabolites in the female reproductive system: Focused on the short-chain fatty acids
Mirzaei, R., Kavyani, B., Nabizadeh, E., Kadkhoda, H., Ozma, M. A., & Abdi, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14562 · Cited by 77
Bradshaw, C. S., Plummer, E. L., Muzny, C. A., Mitchell, C. M., Fredricks, D. N., Herbst‐Kralovetz, M. M., & Vodstrcil, L. A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00626-1 · Cited by 72
Ovarian cycling and reproductive state shape the vaginal microbiota in wild baboons
Miller, E. A., Livermore, J. A., Alberts, S. C., Tung, J., & Archie, E. A. (2017) · Microbiome · doi:10.1186/s40168-017-0228-z · Cited by 65
Vrieze, M. D., Varadarajan, A. R., Schneeberger, K., Bailly, A., Rohr, R. P., Ahrens, C. H., & Weisskopf, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00857 · Cited by 60
Graspeuntner, S., Bohlmann, M. K., Gillmann, K., Speer, R., Küenzel, S., Mark, H., Hoellen, F., Lettau, R., Griesinger, G., König, I. R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191047 · Cited by 61
Frąszczak, K., Barczyński, B., & Kondracka, A. (2022) · Cancers · doi:10.3390/cancers14194909 · Cited by 62
Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant
DeLong, K., Bensouda, S., Zulfiqar, F., Zierden, H. C., Hoang, T., Abraham, A. G., Coleman, J. S., Cone, R. A., Gravitt, P. E., Hendrix, C. W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00306 · Cited by 62
Mutual Preservation: A Review of Interactions Between Cervicovaginal Mucus and Microbiota
Vagios, S., & Mitchell, C. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.676114 · Cited by 56
Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk
Armstrong, E., & Kaul, R. (2021) · Microbiome · doi:10.1186/s40168-021-01183-x · Cited by 66
The Microbiome as a Key Regulator of Female Genital Tract Barrier Function
Plesniarski, A., Siddik, A. B., & Su, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.790627 · Cited by 60
In vitro and ex vivo models for evaluating vaginal drug delivery systems
Shapiro, R. L., DeLong, K., Zulfiqar, F., Carter, D. M., Better, M., & Ensign, L. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114543 · Cited by 58
Dabee, S., Barnabas, S. L., Lennard, K. S., Jaumdally, S. Z., Gamieldien, H., Balle, C., Happel, A., Murugan, B. D., Williamson, A., Mkhize, N. N., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213975 · Cited by 52
Abbasi, A., Aghebati-Maleki, L., & Rad, A. H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1935701 · Cited by 53
Screening of Compounds against Gardnerella vaginalis Biofilms
Gottschick, C., Szafrański, S. P., Kunze, B., Sztajer, H., Masur, C., Abels, C., & Wagner‐Döbler, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154086 · Cited by 54
Balle, C., Lennard, K. S., Dabee, S., Barnabas, S. L., Jaumdally, S. Z., Gasper, M. A., Maseko, V., Mbulawa, Z. Z. A., Williamson, A., Bekker, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29320-x · Cited by 52
Das, S., Bhattacharjee, M. J., Mukherjee, A. K., & Khan, M. R. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2049696 · Cited by 51
Microbial Arsenal of Antiviral Defenses. Part II
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921040064 · Cited by 51
Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections
Tuddenham, S., Ravel, J., & Marrazzo, J. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa762 · Cited by 51
Lactobacillus iners and Genital Health: Molecular Clues to an Enigmatic Vaginal Species
Holm, J. B., Carter, K. A., Ravel, J., & Brotman, R. M. (2023) · Current Infectious Disease Reports · doi:10.1007/s11908-023-00798-5 · Cited by 48
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections
Avitabile, E., Menotti, L., Croatti, V., Giordani, B., Parolin, C., & Vitali, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179168 · Cited by 51
Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in Zambia
Price, J. T., Vwalika, B., Hobbs, M. M., Nelson, J. A. E., Stringer, E. M., Zou, F., Rittenhouse, K., Azcárate-Peril, M. A., Kasaro, M. P., & Stringer, J. S. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223128 · Cited by 44
Nunn, K. L., Clair, G., Adkins, J., Engbrecht, K. M., Fillmore, T., & Forney, L. J. (2020) · mSphere · doi:10.1128/msphere.00943-20 · Cited by 46
Chehoud, C., Stieh, D. J., Bailey, A., Laughlin, A. L., Allen, S. A., McCotter, K. L., Sherrill-Mix, S. A., Hope, T. J., & Bushman, F. D. (2017) · AIDS · doi:10.1097/qad.0000000000001421 · Cited by 45
Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection
González, S. M., Aguilar-Jiménez, W., Su, R., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00144 · Cited by 58
Edwards, V. L., McComb, E. J., Gleghorn, J. P., Forney, L. J., Bavoil, P. M., & Ravel, J. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac026 · Cited by 42
Women-specific routes of administration for drugs: A critical overview
das Neves, J., Notario-Pérez, F., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113865 · Cited by 44
Wessels, J. M., Lajoie, J., Cooper, M. I. J. H., Omollo, K., Felker, A. M., Vitali, D., Dupont, H. A., Nguyen, P. V., Mueller, K., Vahedi, F., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039669 · Cited by 42
Modeling mucus physiology and pathophysiology in human organs-on-chips
Izadifar, Z., Sontheimer-Phelps, A., Lubamba, B., Bai, H., Fadel, C. W., Stejskalová, A., Özkan, A., Dasgupta, Q., Bein, A., Junaid, A., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114542 · Cited by 39
Schroeder, H. A., Nunn, K. L., Schaefer, A., Henry, C. E., Lam, F., Pauly, M. H., Whaley, K. J., Zeitlin, L., Humphrys, M. S., Ravel, J., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0054-z · Cited by 36
Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus
Wessler, T., Chen, A., McKinley, S. A., Cone, R. A., Forest, M. G., & Lai, S. K. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00108 · Cited by 35
Carias, A. M., Allen, S. A., Fought, A. J., Halavaty, K. K., Anderson, M. R., Jimenez, M. L., McRaven, M. D., Gioia, C. J., Henning, T., Kersh, E. N., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005885 · Cited by 34
The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
Seta, F. D., Hoffmann, R., Campisciano, G., Comar, M., Verstraelen, H., Vieira‐Baptista, P., Ventolini, G., & Lev‐Sagie, A. (2021) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000645 · Cited by 34
Correlation between vaginal microbiota and different progression stages of cervical cancer
Wei, B., Chen, Y., Lu, T., Cao, W., Tang, Z., & Yang, H. (2022) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0450 · Cited by 32
HIV Pathogenesis in the Human Female Reproductive Tract
Rodríguez‐García, M., Connors, K. A., & Ghosh, M. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00546-1 · Cited by 36
Schellekens, H. C. J., Schmidt, L., Morré, S. A., van Esch, E. M. G., & van Steenwijk, P. J. D. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093954 · Cited by 39
Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection
Wang, Y., Liu, Z., & Chen, T. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27239 · Cited by 36
ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus
Yang, B., Schaefer, A., Wang, Y., McCallen, J., Lee, P. L., Newby, J., Arora, H., Kumar, P. A., Zeitlin, L., Whaley, K. J., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy230 · Cited by 30
Xu, F., Newby, J., Schiller, J. L., Schroeder, H. A., Wessler, T., Chen, A., Forest, M. G., & Lai, S. K. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00109 · Cited by 29
Novel high-resolution targeted sequencing of the cervicovaginal microbiome
Andralojc, K. M., Molina, M. A., Qiu, M., Spruijtenburg, B., Rasing, M., Pater, B., Huynen, M. A., Dutilh, B. E., Ederveen, T. H. A., Elmelik, D., et al. (2021) · BMC Biology · doi:10.1186/s12915-021-01204-z · Cited by 29
Adapen, C., Réot, L., & Menu, E. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.992176 · Cited by 31
The initial interplay between HIV and mucosal innate immunity
Caputo, V., Libera, M., Sisti, S., Giuliani, B., Diotti, R. A., & Criscuolo, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104423 · Cited by 29
Guo, C., Dai, W., Zhou, Q., Gui, L., Cai, H., Wu, D., Hou, J., Li, C., Li, S. C., Du, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.973875 · Cited by 28
Assessment of microbiota:host interactions at the vaginal mucosa interface
Pruski, P., Lewis, H., Lee, Y. S., Marchesi, J. R., Bennett, P. R., Takáts, Z., & MacIntyre, D. A. (2018) · Methods · doi:10.1016/j.ymeth.2018.04.022 · Cited by 28
O’Hanlon, D. E., Gajer, P., Brotman, R. M., & Ravel, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00106 · Cited by 30
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection
Dai, W., Du, H., Li, S. C., & Wu, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722639 · Cited by 27
Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota
Breedveld, A. C., Schuster, H. J., van Houdt, R., Painter, R. C., Mebius, R. E., van der Veer, C., Bruisten, S. M., Savelkoul, P. H. M., & van Egmond, M. (2022) · Microbiome · doi:10.1186/s40168-021-01198-4 · Cited by 32
Li, W., & Ma, Z. S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.10.033 · Cited by 26
Marín, P. M., da Silva, M. S., Pavani, R., Machado, C. R., & Elias, M. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-23731-6 · Cited by 25
Alizhan, D., Ukybassova, T., Bapayeva, G., Aimagambetova, G. N., Kongrtay, K., Kamzayeva, N., & Terzić, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051521 · Cited by 30
Xiao, B., Wu, C., Song, W., Niu, X., Qin, N., Liu, Z., & Xu, Q. Y. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00189 · Cited by 27
Carter, K. A., France, M., Rutt, L., Bilski, L., Martinez-Greiwe, S., Regan, M. B., Brotman, R. M., & Ravel, J. (2024) · mSphere · doi:10.1128/msphere.00030-24 · Cited by 24
Molina, M. A., Coenen, B. A., Leenders, W. P. J., Andralojc, K. M., Huynen, M. A., & Melchers, W. J. G. (2022) · mBio · doi:10.1128/mbio.01619-22 · Cited by 26
Crosstalk between the Resident Microbiota and the Immune Cells Regulates Female Genital Tract Health
Santacroce, L., Palmirotta, R., Bottalico, L., Charitos, I. A., Colella, M., Topi, S., & Jirillo, E. (2023) · Life · doi:10.3390/life13071531 · Cited by 23
Metadata
- Authors
- Nunn, K. L., Wang, Y.-Y., Harit, D., Humphrys, M. S., Ma, B., Cone, R., Ravel, J., & Lai, S. K.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Department of Biophysics, Johns Hopkins University, Baltimore, Maryland, USA
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Corresponding author
- Lai, Samuel K.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2015-10-30
- Volume
- 6
- Issue
- 5
- Pages
- e01084-15
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC4611035
- OpenAlex
- W2172682788
- Cited by
- 194
- References
- 49
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 13 · 2023: 17 · 2022: 24 · 2021: 34 · 2020: 18 · 2019: 17 · 2018: 22 · 2017: 16 · 2016: 12 · 2015: 3
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- mBio (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (1f32ai102535-01)
- University of North Carolina at Chapel Hill
- National Institute of General Medical Sciences (R25GM089569)
- National Institute of Allergy and Infectious Diseases (U19AI084044, R21AI093242, F32 AI102535, U19AI096398, P30 AI50410, 1F32AI102535, P30AI050410)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- HIV-1, cervicovaginal mucus, vaginal microbiota, Lactobacillus crispatus, Lactobacillus iners, Gardnerella vaginalis, bacterial vaginosis, mucus barrier, virus trapping, D-lactate, HIV acquisition, sexually transmitted infections, particle tracking
- MeSH terms
- Adult, Cervix Uteri, Female, Gardnerella vaginalis, Humans, Hydrogen-Ion Concentration, Lactobacillus, Mucus, Vagina, HIV-1, Lactic Acid, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review